Showing results (3621-3630 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|October 5, 2006
Cross-reactivity in cell-mediated and IgE-mediated hypersensitivity to glucocorticoidsM T Ventura, G F Calogiuri, L Muratore, et al.Current Pharmaceutical Design|October 5, 2006
Cardiovascular effects of phosphodiesterase 5 inhibitorsThorsten Reffelmann, Robert A KlonerCurrent Pharmaceutical Design|October 5, 2006
Possible therapies of septic shock: based on animal studies and clinical trialsC C WuCurrent Pharmaceutical Design|September 24, 2004
Radiolabeled compounds in the development of cytotoxic agentsKalevi J A Kairemo, Marja TähtinenCurrent Pharmaceutical Design|September 24, 2004
Radiolabeled compounds in diagnosis of infectious and inflammatory diseaseC P Bleeker-Rovers, O C Boerman, H J J M Rennen, et al.Current Pharmaceutical Design|September 24, 2004
Imaging drug resistance with radiolabeled moleculesG Vaidyanathan, M R ZalutskyCurrent Pharmaceutical Design|September 24, 2004
The use of radiolabeled compounds for ADME studies in discovery and exploratory developmentP H Marathe, W C Shyu, W G HumphreysCurrent Pharmaceutical Design|September 24, 2004
Design, synthesis and preclinical evaluation of radiolabeled peptides for diagnosis and therapyL Aloj, G MorelliCurrent Pharmaceutical Design|September 24, 2004
Transcription factors in autoimmune diseasesMartin Eggert, Andreas Klüter, Uwe K Zettl, et al.Current Pharmaceutical Design|September 24, 2004
Pituitary adenylate cyclase activating polypeptide: a potential neuroprotective peptideAnikó Somogyvári-Vigh, Dóra ReglodiPageof 1,008